journal article·2024-09-18Open access

Synthesis, Photo-Characterizations, and Pre-Clinical Studies on Advanced Cellular and Animal Models of Zinc(II) and Platinum(II) Sulfonyl-Substituted Phthalocyanines for Enhanced Vascular-Targeted Photodynamic Therapy

Paweł Repetowski, Marta Warszyńska, Anna Kostecka, Barbara Pucelik, Agata Barzowska, Atefeh Emami, Ümit İşci, Fabienne Dumoulin, Janusz M. Dąbrowski

ACS Applied Materials & Interfaces· Volume 16· Issue 37

Abstract

High Resolution Image Download MS PowerPoint Slide Two phthalocyanine derivatives tetra-peripherally substituted with tert -butylsulfonyl groups and coordinating either zinc(II) or platinum(II) ions have been synthesized and subsequently investigated in terms of their optical and photochemical properties, as well as biological activity in cellular, tissue-engineered, and animal models. Our research has revealed that both synthesized phthalocyanines are effective generators of reactive oxygen species (ROS). PtSO 2 t Bu demonstrated an outstanding ability to generate singlet oxygen (Φ Δ = 0.87–0.99), while ZnSO 2 t Bu in addition to 1 O 2 (Φ Δ = 0.45–0.48) generated efficiently other ROS, in particular ·OH. Considering future biomedical applications, the affinity of the tested phthalocyanines for biological membranes (partition coefficient; log P ow ) and their primary interaction with serum albumin were also determined. To facilitate their biological administration, a water-dispersible formulation of these phthalocyanines was developed using Pluronic triblock copolymers to prevent self-aggregation and improve their delivery to cancer cells and tissues. The results showed a significant increase in cellular uptake and phototoxicity when phthalocyanines were incorporated into the customizable polymeric micelles. Moreover, the improved distribution in the body and photodynamic efficacy of the encapsulated phthalocyanines were investigated in hiPSC-delivered organoids and BALB/c mice bearing CT26 tumors. Both photosensitizers exhibit strong antitumor activity. Notably, vascular-targeted photodynamic therapy (V-PDT) led to complete tumor eradication in 84% of ZnSO 2 t Bu and 100% of PtSO 2 t Bu- treated mice, and no recurrence has so far been observed for up to five months after treatment. In the case of PtSO 2 t Bu, the effect was significantly stronger, offering a wider range of light doses suitable for achieving effective PDT.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Porphyrin and Phthalocyanine Chemistry · Photodynamic Therapy Research Studies · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Faculty of Chemistry, Jagiellonian University, Kraków 30-387, Poland

Doctoral School of Exact and Natural Sciences, Jagiellonian University, Kraków 30-348, Poland

Małopolska Centre of Biotechnology, Jagiellonian University, Kraków 30-387, Poland

Łukasiewicz Research Network─Kraków Institute of Technology, Kraków 30-418, Poland

Faculty of Engineering and Natural Sciences, Department of Biomedical Engineering, Acıbadem Mehmet Ali Aydınlar University, Ataşehir, Istanbul 34752, Türkiye

Faculty of Technology, Department of Metallurgical & Materials Engineering, Marmara University, Istanbul 34722, Türkiye

Funding

Narodowe Centrum Nauki

References (70)

Show source-provided references
1. 10.3390/ijms2122871610.3390/ijms21228716 ↗
2. 10.1016/j.pdpdt.2018.05.00110.1016/j.pdpdt.2018.05.001 ↗
3. 10.1016/bs.adioch.2021.12.00310.1016/bs.adioch.2021.12.003 ↗
4. 10.1016/j.ejmech.2019.11174010.1016/j.ejmech.2019.111740 ↗
5. 10.1021/acsinfecdis.2c0013110.1021/acsinfecdis.2c00131 ↗
6. 10.1039/c5pp00132c10.1039/c5pp00132c ↗
7. Dąbrowski J. M. · 2017 · 70 · 343
8. 10.1142/S108842461930002710.1142/S1088424619300027 ↗
9. 10.1016/j.ejca.2015.06.00210.1016/j.ejca.2015.06.002 ↗
10. 10.1016/j.ccr.2023.21535010.1016/j.ccr.2023.215350 ↗
11. 10.1016/j.ymeth.2016.06.02510.1016/j.ymeth.2016.06.025 ↗
12. 10.1142/S108842461950089510.1142/S1088424619500895 ↗
13. 10.1016/j.jphotobiol.2009.04.00110.1016/j.jphotobiol.2009.04.001 ↗
14. 10.1002/chem.20100011110.1002/chem.201000111 ↗
15. 10.1002/cmdc.20100022310.1002/cmdc.201000223 ↗
16. 10.1016/S1572-1000(05)00030-X10.1016/S1572-1000(05)00030-X ↗
17. 10.1016/j.ccr.2010.05.00210.1016/j.ccr.2010.05.002 ↗
18. 10.1016/j.poly.2008.11.02110.1016/j.poly.2008.11.021 ↗
19. 10.1667/0033-7587(2001)155[0015:EOODIR]2.0.CO;210.1667/0033-7587(2001)155[0015:EOODIR]2.0.CO;2 ↗
20. 10.1016/j.nano.2017.02.00210.1016/j.nano.2017.02.002 ↗
21. 10.1039/C9CC05703J10.1039/C9CC05703J ↗
22. 10.1021/acs.molpharmaceut.3c0030610.1021/acs.molpharmaceut.3c00306 ↗
23. 10.1142/S108842461950189X10.1142/S108842461950189X ↗
24. 10.1016/j.ejmech.2016.08.03510.1016/j.ejmech.2016.08.035 ↗
25. 10.1016/j.addr.2003.07.01310.1016/j.addr.2003.07.013 ↗
26. 10.1016/j.tibtech.2008.07.00710.1016/j.tibtech.2008.07.007 ↗
27. 10.2174/09298671279903489710.2174/092986712799034897 ↗
28. 10.1016/j.ijpharm.2011.11.04510.1016/j.ijpharm.2011.11.045 ↗
29. 10.1021/acsami.1c2315610.1021/acsami.1c23156 ↗
30. 10.1021/acsami.9b1262010.1021/acsami.9b12620 ↗
31. 10.1016/j.ejpb.2016.03.02810.1016/j.ejpb.2016.03.028 ↗
32. 10.1039/c3dt53410c10.1039/c3dt53410c ↗
33. 10.1039/C5CC01085C10.1039/C5CC01085C ↗
34. 10.1002/chem.20030483410.1002/chem.200304834 ↗
35. 10.1021/acscentsci.8b0056510.1021/acscentsci.8b00565 ↗
36. 10.1016/j.tet.2010.02.07910.1016/j.tet.2010.02.079 ↗
37. 10.1016/j.pdpdt.2015.10.01010.1016/j.pdpdt.2015.10.010 ↗
38. 10.1371/journal.pone.009789410.1371/journal.pone.0097894 ↗
39. 10.1039/D1CS00609F10.1039/D1CS00609F ↗
40. 10.1021/cm900383c10.1021/cm900383c ↗
41. 10.3109/10408444.2013.83615510.3109/10408444.2013.836155 ↗
42. 10.1016/j.ejps.2004.06.00410.1016/j.ejps.2004.06.004 ↗
43. 10.1002/ijc.1029910.1002/ijc.10299 ↗
44. 10.1039/c3pp25419d10.1039/c3pp25419d ↗
45. 10.1002/chem.20130420210.1002/chem.201304202 ↗
46. 10.1002/lsm.2293110.1002/lsm.22931 ↗
47. 10.1159/00049342310.1159/000493423 ↗
48. 10.1111/j.1751-1097.1988.tb02778.x10.1111/j.1751-1097.1988.tb02778.x ↗
49. 10.1016/S0022-2860(03)00155-810.1016/S0022-2860(03)00155-8 ↗
50. 10.1016/j.jbbm.2005.10.00310.1016/j.jbbm.2005.10.003 ↗
51. 10.1016/S0169-409X(00)00129-010.1016/S0169-409X(00)00129-0 ↗
52. 10.1080/13102818.2014.91507710.1080/13102818.2014.915077 ↗
53. 10.1021/bi00514a01710.1021/bi00514a017 ↗
54. 10.1080/15257770.2016.122633810.1080/15257770.2016.1226338 ↗
55. 10.1039/b416304d10.1039/b416304d ↗
56. 10.1021/acsami.6b0703110.1021/acsami.6b07031 ↗
57. 10.1016/j.jconrel.2008.04.01310.1016/j.jconrel.2008.04.013 ↗
58. 10.1073/pnas.95.26.1566510.1073/pnas.95.26.15665 ↗
59. 10.1186/1471-2164-15-19010.1186/1471-2164-15-190 ↗
60. 10.21926/obm.genet.180303710.21926/obm.genet.1803037 ↗
61. 10.1002/dvg.2287410.1002/dvg.22874 ↗
62. 10.1517/17460441.2015.107961810.1517/17460441.2015.1079618 ↗
63. 10.1002/gcc.2073010.1002/gcc.20730 ↗
64. 10.5732/cjc.011.1004110.5732/cjc.011.10041 ↗
65. 10.1021/acsami.2c0110010.1021/acsami.2c01100 ↗
66. 10.1002/mco2.27410.1002/mco2.274 ↗
67. 10.1038/nm.435510.1038/nm.4355 ↗
68. 10.1021/jp900580e10.1021/jp900580e ↗
69. 10.1111/j.1745-7254.2006.00340.x10.1111/j.1745-7254.2006.00340.x ↗
70. 10.3390/ani910075410.3390/ani9100754 ↗